Glutamine inhibits platelet-activating factor-mediated pulmonary tumour metastasis.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  European Journal of Cancer

• Publication date

  2012-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ejca.2011.07.013PMID 21889331
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Glutamine Protects Mice from Lethal Endotoxic Shock via a Rapid Induction of MAPK Phosphatase-11

  2009cited by this paper
• The complexity of mitogen-activated protein kinases (MAPKs) made simple

  2008cited by this paper
• Tumor growth, angiogenesis and inflammation in mice lacking receptors for platelet activating factor (PAF).

  2007cited by this paper
• Macrophages: obligate partners for tumor cell migration, invasion, and metastasis.

  2006cited by this paper
• GLUTAMINE INHIBITS LIPOPOLYSACCHARIDE-INDUCED CYTOPLASMIC PHOSPHOLIPASE A2 ACTIVATION AND PROTECTS AGAINST ENDOTOXIN SHOCK IN MOUSE

  2006cited by this paper
• Platelet-Activating Factor Induces Up-regulation of Antiapoptotic Factors in a Melanoma Cell Line through Nuclear Factor-κB Activation

  2006cited by this paper
• Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-kappaB activation.

  2006cited by this paper
• Chemokines and cancer

  2006cited by this paper
• NF-kappaB: linking inflammation and immunity to cancer development and progression.

  2005cited by this paper
• Activation and signaling of the p38 MAP kinase pathway

  2005cited by this paper
• Involvement of matrix metalloproteinase‐9 in platelet‐activating factor‐induced angiogenesis

  2005cited by this paper
• The fibroblastic coconspirator in cancer progression.

  2005cited by this paper
• NF-κB: linking inflammation and immunity to cancer development and progression

  2005cited by this paper
• The biology of p38 kinase: a central role in inflammation.

  2005cited by this paper
• Functions of MAP kinases: insights from gene-targeting studies.

  2004cited by this paper
• Cancer research. Inflammation and cancer: the link grows stronger.

  2004cited by this paper
• Inflammation and Cancer: The Link Grows Stronger

  2004cited by this paper
• The p38 MAP kinase pathway as a therapeutic target in inflammatory disease.

  2004cited by this paper
• Possible novel therapy for diabetes with cell-permeable JNK-inhibitory peptide

  2004cited by this paper
• Essential role for platelet‐activating factor‐induced NF‐κB activation in macrophage‐derived angiogenesis

  2004cited by this paper
• l-glutamine: a major substrate for tumor cells in vivo?

  2004cited by this paper
• Constitutive activation of the MAPkinase p38 is critical for MMP-9 production and survival of B-CLL cells on bone marrow stromal cells

  2004cited by this paper
• p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases

  2003cited by this paper
• Transcriptional and post-transcriptional control of gene expression in inflammation.

  2002cited by this paper
• Inflammation and cancer

  2002cited by this paper
• Nuclear Factor κB Dependency of Platelet-activating Factor-induced Angiogenesis

  2002cited by this paper
• New functions for the matrix metalloproteinases in cancer progression

  2002cited by this paper
• Nuclear factor kappaB dependency of platelet-activating factor-induced angiogenesis.

  2002cited by this paper
• Regulation of the Metastatic Process by E‐Selectin and Stress‐Activated Protein Kinase‐2/p38

  2002cited by this paper
• Glutamine reduces cytokine release, organ damage, and mortality in a rat model of endotoxemia.

  2001cited by this paper
• Platelet-Activating Factor-Induced Early Activation of NF-κB Plays a Crucial Role for Organ Clearance of Candida albicans1

  2001cited by this paper
• Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.

  2001cited by this paper
• PGE(2) stimulates VEGF expression in endothelial cells via ERK2/JNK1 signaling pathways.

  2001cited by this paper
• Signal Pathways Which Promote Invasion and Metastasis: Critical and Distinct Contributions of Extracellular Signal-Regulated Kinase and Ral-Specific Guanine Exchange Factor Pathways

  2001cited by this paper
• c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis.

  2001cited by this paper
• Inflammation and cancer: back to Virchow?

  2001cited by this paper
• Urokinase plasminogen activator/urokinase-specific surface receptor expression and matrix invasion by breast cancer cells requires constitutive p38alpha mitogen-activated protein kinase activity.

  2000cited by this paper
• Signaling angiogenesis via p42/p44 MAP kinase and hypoxia.

  2000cited by this paper
• Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model.

  2000cited by this paper
• Urokinase Plasminogen Activator/Urokinase-specific Surface Receptor Expression and Matrix Invasion by Breast Cancer Cells Requires Constitutive p38α Mitogen-activated Protein Kinase Activity*

  2000cited by this paper
• Constitutive activation of the 41-/43-kDa mitogen-activated protein kinase signaling pathway in human tumors

  1999cited by this paper
• Mitogen‐activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP‐9) in breast epithelial cells

  1999cited by this paper
• Regulation of matrix metalloproteinase expression in tumor invasion

  1999cited by this paper
• Investigation of the Mek-MAP kinase-Rsk pathway in human breast cancer.

  1999cited by this paper
• In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms.

  1998cited by this paper
• Induction of in vitro angiogenesis in the endothelial-derived cell line, EA hy926, by ethanol is mediated through PKC and MAPK.

  1998cited by this paper
• Hepatic glutamine transport and metabolism.

  1998cited by this paper
• Extracellular Signal-regulated Protein Kinase/Jun Kinase Cross-talk Underlies Vascular Endothelial Cell Growth Factor-induced Endothelial Cell Proliferation*

  1998cited by this paper
• Lasting N-Terminal Phosphorylation of c-Jun and Activation of c-Jun N-Terminal Kinases after Neuronal Injury

  1998cited by this paper
• The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis.

  1998cited by this paper
• Integrin αvβ3 Requirement for Sustained Mitogen-activated Protein Kinase Activity during Angiogenesis

  1998cited by this paper
• Evidence for a role of Met-HGF/SF during Ras-mediated tumorigenesis/metastasis

  1998cited by this paper
• Dietary L-glutamine supplementation reduces the growth of the Morris Hepatoma 7777 in exercise-trained and sedentary rats.

  1997cited by this paper
• Involvement of nuclear factor-kappa B in platelet-activating factor-mediated tumor necrosis factor-alpha expression.

  1997cited by this paper
• Involvement of nuclear factor‐xB in platelet‐activating factor‐mediated tumor necrosis factor‐α expression

  1997cited by this paper
• Hyperexpression of mitogen-activated protein kinase in human breast cancer.

  1997cited by this paper
• Six-month outcome of critically ill patients given glutamine-supplemented parenteral nutrition.

  1997cited by this paper
• Glutamine suppresses PGE2 synthesis and breast cancer growth.

  1996cited by this paper
• Augmentation of tumor metastasis by platelet-activating factor.

  1996cited by this paper
• The Role of Glutamine and Other Alternate Substrates as Energy Sources in the Fetal Rat Lung Type II Cell1

  1996cited by this paper
• Mechanism and regulation of neutrophil priming by platelet‐activating factor

  1993cited by this paper
• Effects of platelet activating factor (PAF) and other vasoconstrictors on a model of angiogenesis in the mouse.

  1992cited by this paper
• Platelet‐activating factor receptor and signal transduction mechanisms 1

  1992cited by this paper
• Glutamine-enriched diets support muscle glutamine metabolism without stimulating tumor growth.

  1990cited by this paper
• Perspectives in platelet-activating factor research.

  1987cited by this paper
• Glutamine metabolism in lymphocytes: its biochemical, physiological and clinical importance.

  1985cited by this paper
• The role of glutamine in the oxidative metabolism of malignant cells.

  1972cited by this paper
• A series of transplantable rat mammary tumors with graded differentiation, growth rate, and glutaminase content.

  1970cited by this paper

• Glutamine metabolism in tumor metastasis: Genes, mechanisms and the therapeutic targets

  2023cites this paper
• CAR-T therapy alters synthesis of platelet-activating factor in multiple myeloma patients

  2021cites this paper
• Analysis of differential metabolites in lung cancer patients based on metabolomics and bioinformatics.

  2020cites this paper
• Non-canonical roles for metabolic enzymes and intermediates in malignant progression and metastasis

  2019cites this paper
• Platelet activating factor receptor antagonists improve the efficacy of experimental chemo- and radiotherapy

  2018cites this paper
• Cholera Toxin Disrupts Oral Tolerance via NF-κB-mediated Downregulation of Indoleamine 2,3-dioxygenase Expression

  2017cites this paper
• Nuclear localization of platelet-activating factor receptor controls retinal neovascularization

  2016cites this paper
• Preconditioning with Glutamine Protects against Ischemia/Reperfusion-Induced Hepatic Injury in Rats with Obstructive Jaundice

  2014cites this paper
• Cholera toxin breakdowns oral tolerance via activation of canonical NF-κB.

  2013cites this paper
• PTEN/MAPK pathways play a key role in platelet‐activating factor‐induced experimental pulmonary tumor metastasis

  2012cites this paper